Clinical Trial Update: A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2a trial evaluating the safety and pharmacokinetics of Rhu-plasma Gelsolin in hospitalized adults with community-acquired pneumonia; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Rhu-plasma Gelsolin (rhu-plasma gelsolin)

Snippet

Sponsor: BioAegis Therapeutics Inc. | Conditions: Community-acquired Pneumonia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-27